• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环境中药物的转化产物:它们的命运、(生态)毒性和生物蓄积潜力。

Transformation products of pharmaceuticals in the environment: Their fate, (eco)toxicity and bioaccumulation potential.

机构信息

Department of Environmental Analysis, Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, 80-308 Gdańsk, Poland.

Department of Environmental Analysis, Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, 80-308 Gdańsk, Poland.

出版信息

Sci Total Environ. 2022 Jan 1;802:149916. doi: 10.1016/j.scitotenv.2021.149916. Epub 2021 Aug 27.

DOI:10.1016/j.scitotenv.2021.149916
PMID:34525754
Abstract

Nowadays, a huge scientific attention is being paid to the chemicals of emerging concern, which may pose a significant risk to the human and whole ecosystems. Among them, residues of pharmaceuticals are a widely investigated group of chemicals. In recent years it has been repeatedly demonstrated that pharmaceuticals are present in the environment and that some of them can be toxic to organisms as well as accumulate in their tissues. However, even though the knowledge of the presence, fate and possible threats posed by the parent forms of pharmaceuticals is quite extensive, their transformation products (TPs) have been disregarded for long time. Since last few years, this aspect has gained more scientific attention and recently published papers proved their common presence in the environment. Also the interest in terms of their toxicity, bioconcentration and stability in the environment has increased. Therefore, the aim of our paper was to revise and assess the current state of knowledge on the fate and effects resulting from the presence of the pharmaceuticals' transformation drugs in the environment. This review discusses the metabolites of compounds belonging to six major pharmaceutical groups: SSRIs, anticancer drugs, antibiotics, antihistamines, NSAIDs and opioids, additionally discussing other individual compounds for which literature data exist. The data presented in this paper prove that some TPs may be as harmful as their native forms, however for many groups of drugs this data is still insufficient to assess the risk posed by their presence in the environment.

摘要

如今,人们对新兴关注的化学物质给予了极大的关注,这些物质可能会对人类和整个生态系统造成重大风险。其中,药物残留是一个广泛研究的化学物质群体。近年来,人们反复证明药物存在于环境中,其中一些物质对生物体有毒,并且可以在其组织中积累。然而,尽管对于药物的母体形式的存在、命运和可能构成的威胁的认识已经相当广泛,但它们的转化产物 (TPs) 长期以来一直被忽视。近年来,这方面引起了更多的科学关注,最近发表的论文证明了它们在环境中的普遍存在。同时,人们对其毒性、生物浓缩和在环境中的稳定性的兴趣也有所增加。因此,我们的论文旨在综述和评估环境中药物转化药物存在的命运和影响的现有知识状况。本文讨论了属于六大主要药物类别的化合物的代谢物:SSRIs、抗癌药物、抗生素、抗组胺药、NSAIDs 和阿片类药物,此外还讨论了其他存在文献数据的个别化合物。本文介绍的数据证明,一些 TPs 可能与它们的母体形式一样有害,但是对于许多药物类别,这方面的数据仍然不足以评估它们在环境中存在所带来的风险。

相似文献

1
Transformation products of pharmaceuticals in the environment: Their fate, (eco)toxicity and bioaccumulation potential.环境中药物的转化产物:它们的命运、(生态)毒性和生物蓄积潜力。
Sci Total Environ. 2022 Jan 1;802:149916. doi: 10.1016/j.scitotenv.2021.149916. Epub 2021 Aug 27.
2
Ecotoxicity screening evaluation of selected pharmaceuticals and their transformation products towards various organisms.选择的药品及其转化产物对各种生物的生态毒性筛选评价。
Environ Sci Pollut Res Int. 2020 Jul;27(21):26103-26114. doi: 10.1007/s11356-020-08881-3. Epub 2020 May 1.
3
Presence of pharmaceuticals and their metabolites in wild-living aquatic organisms - Current state of knowledge.药品及其代谢物在野生水生生物中的存在 - 现有知识状况。
J Hazard Mater. 2022 Feb 15;424(Pt A):127350. doi: 10.1016/j.jhazmat.2021.127350. Epub 2021 Sep 26.
4
Interaction of pharmaceutical metabolites with blood proteins and membrane lipids in the view of bioconcentration: A preliminary study based on in vitro assessment.从生物浓缩的角度看药物代谢物与血液蛋白和膜脂质的相互作用:基于体外评估的初步研究。
Sci Total Environ. 2021 Aug 20;783:146987. doi: 10.1016/j.scitotenv.2021.146987. Epub 2021 Apr 9.
5
Bioconcentration of neuroactive pharmaceuticals in fish: Relation to lipophilicity, experimental design and toxicity in the aquatic environment.生物体内神经活性药物的富集:与亲脂性、实验设计和水生环境毒性的关系。
Sci Total Environ. 2022 Mar 15;812:152543. doi: 10.1016/j.scitotenv.2021.152543. Epub 2021 Dec 23.
6
Bioaccumulation and biomagnification potential of pharmaceuticals with a focus to the aquatic environment.重点关注水生环境的药物的生物累积和生物放大潜力。
J Environ Manage. 2014 Jan 15;133:378-87. doi: 10.1016/j.jenvman.2013.12.017. Epub 2014 Jan 11.
7
Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: an application to the Spanish case.基于环境指标的药品和个人护理产品关注度排名:以西班牙为例的应用。
J Environ Manage. 2013 Nov 15;129:384-97. doi: 10.1016/j.jenvman.2013.06.035. Epub 2013 Aug 28.
8
Occurrence, fate and transformation of emerging contaminants in water: An overarching review of the field.水中新兴污染物的发生、归宿与转化:该领域的全面综述
Environ Pollut. 2017 Dec;231(Pt 1):954-970. doi: 10.1016/j.envpol.2017.08.032. Epub 2017 Sep 25.
9
Bioaccumulation/bioconcentration of pharmaceutical active compounds in aquatic organisms: Assessment and factors database.水生生物中药物活性化合物的生物累积/生物富集:评估与影响因素数据库
Sci Total Environ. 2023 Feb 25;861:160638. doi: 10.1016/j.scitotenv.2022.160638. Epub 2022 Dec 5.
10
Illicit drugs: contaminants in the environment and utility in forensic epidemiology.非法药物:环境污染物及其在法医流行病学中的应用。
Rev Environ Contam Toxicol. 2011;210:59-110. doi: 10.1007/978-1-4419-7615-4_3.

引用本文的文献

1
Continuous improvement towards environmental protection for pharmaceuticals: advancing a strategy for Europe.制药行业环境保护的持续改进:推进欧洲战略
Environ Sci Eur. 2025;37(1):128. doi: 10.1186/s12302-025-01180-z. Epub 2025 Jul 26.
2
Removal of psychopharmaceuticals from WWTP effluent by an algae-mussel trophic cascade: a potential nature-based solution?通过藻类-贻贝营养级联从污水处理厂废水中去除精神药物:一种潜在的基于自然的解决方案?
Environ Sci (Camb). 2025 May 9. doi: 10.1039/d5ew00011d.
3
Presence, removal, and risks of psychopharmaceuticals in wastewater streams.
废水流中精神药物的存在、去除及风险
Environ Toxicol Chem. 2025 Feb 1;44(2):375-385. doi: 10.1093/etojnl/vgae042.
4
Microbes as Resources to Remove PPCPs and Improve Water Quality.微生物作为去除药物和个人护理产品及改善水质的资源
Microb Biotechnol. 2025 Jan;18(1):e70084. doi: 10.1111/1751-7915.70084.
5
Comparative Study on the Removal Efficiency of Clomazone and Amitriptyline via Adsorption and Photocatalysis in Aqueous Media: Kinetic Models and Toxicity Assessment.水相中通过吸附和光催化去除广灭灵和阿米替林的效率比较研究:动力学模型与毒性评估
Materials (Basel). 2024 Mar 16;17(6):1369. doi: 10.3390/ma17061369.
6
Adsorption of contaminants by nanomaterials synthesized by green and conventional routes: a critical review.绿色和传统路线合成纳米材料对污染物的吸附:批判性评价。
Environ Sci Pollut Res Int. 2024 Feb;31(9):12683-12721. doi: 10.1007/s11356-024-31922-0. Epub 2024 Jan 23.
7
Diclofenac, ibuprofen, and paracetamol biodegradation: overconsumed non-steroidal anti-inflammatories drugs at COVID-19 pandemic.双氯芬酸、布洛芬和对乙酰氨基酚的生物降解:COVID-19大流行期间过度消费的非甾体抗炎药
Front Microbiol. 2023 Oct 30;14:1207664. doi: 10.3389/fmicb.2023.1207664. eCollection 2023.
8
Assessment of the Presence of Transformation Products of Certain Pharmaceutical Products (Psychotropic Family) by Suspect and Non-Targeted HRMS Screening in Wastewater Treatment Plants.通过在污水处理厂进行可疑和非靶向高分辨率质谱筛查评估某些药品(精神药物类)转化产物的存在情况
Toxics. 2023 Aug 18;11(8):713. doi: 10.3390/toxics11080713.
9
Investigating the Transformation Products of Selected Antibiotics and 17 α-Ethinylestradiol under Three In Vitro Biotransformation Models for Anticipating Their Relevance in Bioaugmented Constructed Wetlands.在三种体外生物转化模型下研究选定抗生素和17α-乙炔雌二醇的转化产物,以预测它们在生物强化人工湿地中的相关性。
Toxics. 2023 Jun 5;11(6):508. doi: 10.3390/toxics11060508.
10
Distribution, Bioaccumulation, and Risks of Pharmaceutical Metabolites and Their Parents: A Case Study in an Yunliang River, Nanjing City.药物代谢物及其母体在水体中的分布、生物积累及风险:以南京市运粮河为例。
Int J Environ Res Public Health. 2023 Feb 8;20(4):2967. doi: 10.3390/ijerph20042967.